The increasing focus on precision diagnostics and targeted therapeutics is driving substantial demand for FAM20B gene and XYLK antibody research applications across the life sciences sector. Growing investments in genomic studies, biomarker identification, and personalized medicine are encouraging research institutions and biopharmaceutical companies to expand the use of advanced antibody...